Literature DB >> 1572956

Nonmycetomic Actinomadura madurae infection in a patient with AIDS.

M M McNeil1, J M Brown, G Scalise, C Piersimoni.   

Abstract

Actinomadura madurae is an aerobic actinomycete which is best known worldwide as the cause of actinomycotic mycetomas. It has not previously been reported to have caused invasive pulmonary or disseminated infection in humans. We describe an AIDS patient with opportunistic A. madurae-induced pneumonia and bacteremia. The isolate from the patient's blood was subjected to dilutional antimicrobial susceptibility tests with 12 antimicrobial agents and was found to have a wide spectrum of susceptibility. This unusual microorganism may be a cause of infections in severely immunosuppressed patients.

Entities:  

Mesh:

Year:  1992        PMID: 1572956      PMCID: PMC265203          DOI: 10.1128/jcm.30.4.1008-1010.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens.

Authors:  M M McNeil; J M Brown; W R Jarvis; L Ajello
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

2.  Peritonitis caused by Actinomadura madurae in a patient on CAPD.

Authors:  J Wüst; H Lanzendörfer; A von Graevenitz; H J Gloor; B Schmid
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

3.  Laboratory identification of clinically important aerobic actinomycetes.

Authors:  D Berd
Journal:  Appl Microbiol       Date:  1973-04

4.  Identification of aerobic actinomycetes of clinical importance.

Authors:  M P Lechevalier
Journal:  J Lab Clin Med       Date:  1968-06

5.  Actinomycetoma in the United States.

Authors:  R R Tight; M S Bartlett
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

6.  Molecular-genetic and chemotaxonomic studies on Actinomadura and Nocardiopsis.

Authors:  A Fischer; R M Kroppenstedt; E Stackebrandt
Journal:  J Gen Microbiol       Date:  1983-11

7.  RAPID DIFFERENTIATION BETWEEN NOCARDIA AND STREPTOMYCES BY PAPER CHROMATOGRAPHY OF WHOLE-CELL HYDROLYSATES.

Authors:  B BECKER; M P LECHEVALIER; R E GORDON; H A LECHEVALIER
Journal:  Appl Microbiol       Date:  1964-09
  7 in total
  5 in total

1.  Majority of Actinomadura clinical isolates from sputa or bronchoalveolar lavage fluid in Japan belongs to the cluster of Actinomadura cremea and Actinomadura nitritigenes, and the description of Actinomadura chibensis sp. nov.

Authors:  Ahmed Hanafy; Junji Ito; Soji Iida; Yingqian Kang; Takahisa Kogure; Katsukiyo Yazawa; Takashi Yaguchi; Yuzuru Mikami
Journal:  Mycopathologia       Date:  2006-10       Impact factor: 2.574

2.  Tuning the Mycobacterium tuberculosis Alternative Sigma Factor SigF through the Multidomain Regulator Rv1364c and Osmosensory Kinase Protein Kinase D.

Authors:  Richa Misra; Dilip Menon; Gunjan Arora; Richa Virmani; Mohita Gaur; Saba Naz; Neetika Jaisinghani; Asani Bhaduri; Ankur Bothra; Abhijit Maji; Anshika Singhal; Preeti Karwal; Christian Hentschker; Dörte Becher; Vivek Rao; Vinay K Nandicoori; Sheetal Gandotra; Yogendra Singh
Journal:  J Bacteriol       Date:  2019-03-13       Impact factor: 3.490

Review 3.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Molecular diagnosis of Actinomadura madurae infection by 16S rRNA deep sequencing.

Authors:  Stephen J Salipante; Dhruba J Sengupta; Daniel R Hoogestraat; Lisa A Cummings; Bronwyn H Bryant; Catherine Natividad; Stephanie Thielges; Peter W Monsaas; Mimosa Chau; Lindley A Barbee; Christopher Rosenthal; Brad T Cookson; Noah G Hoffman
Journal:  J Clin Microbiol       Date:  2013-10-09       Impact factor: 5.948

5.  Identification and antimicrobial susceptibility of Streptomyces and other unusual Actinobacteria clinical isolates in Spain.

Authors:  J A Sáez-Nieto; G Carrasco; S Del Pino; M J Medina-Pascual; N Garrido; P Villalón; S Valdezate
Journal:  New Microbes New Infect       Date:  2021-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.